Mevalonate kinase deficiencies: From mevalonic aciduria to hyperimmunoglobulinemia D syndrome

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Haas, Dorothea ^a   Hoffmann, Georg F ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN D; MEVALONATE KINASE; MEVALONIC ACID; PHOSPHOTRANSFERASE; SIMVASTATIN;

GENETICS; HUMAN; HYPERGAMMAGLOBULINEMIA; METABOLISM; PATHOLOGY; REVIEW; SYNDROME; URINE;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN D; MEVALONIC ACID; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIMVASTATIN; SYNDROME;

EID: 34248325296     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-13     Document Type: Review

References (27)

1. Mevalonic aciduria - an inborn error of cholesterol and nonsterol isoprene biosynthesis. G Hoffmann KM Gibson IK Brandt PI Bader RS Wappner L Sweetman, N Engl J Med 1986 314 1610 1614 3012338
2. Mevalonate kinase map position 12q24. KM Gibson GF Hoffmann RD Tanaka RW Bishop KL Chambliss, Chromosome research 1997 5 150 10.1023/A:1018430527386 9146921
3. Mevalonate kinase deficiency - Evidence for a phenotypic continuum. A Simon HP Kremer RA Wevers H Scheffer JG De Jong JW Van Der Meer JP Drenth, Neurology 2004 62 994 997 15037710
4. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. GF Hoffmann C Charpentier E Mayatepek J Mancini M Leichsenring KM Gibson P Divry M Hrebicek W Lehnert K Sartor, Pediatrics 1993 91 915 921 8386351
5. Mevalonate kinase deficiency -enlarging the clinical and biochemical spectrum. V Prietsch E Mayatepek H Krastel D Haas D Zundel HR Waterham RJ Wanders KM Gibson GF Hoffmann, Pediatrics 2003 111 258 261 10.1542/peds.111.2. 258 12563048
6. Hereditary periodic fever. JP Drenth JW van den Meer, N Engl J Med 2001 345 1748 1757 10.1056/NEJMra010200 11742050
7. Organisation of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. SM Houten J Koster GJ Romeijn J Frenkel M Di Rocco U Caruso P Landrieu RI Kelley W Kuis BT Poll-The KM Gibson RJA Wanders HR Waterham, Eur J Hum Genet 2001 9 253 259 10.1038/sj.ejhg.5200595 11313768
8. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. L Cuisset JP Drenth A Simon MF Vincent S van der Velde Visser JW van der Meer G Grateau M Delpech, Eur J Hum Genet 2001 9 260 266 10.1038/sj.ejhg.5200614 11313769
9. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. SM Houten J Frenkel GT Rijkers RJ Wanders W Kuis HR Waterham, Hum Mol Genet 2002 11 3115 3124 10.1093/hmg/11.25.3115 12444096
10. Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency. DD Hinson ZR Rogers GF Hoffmann M Schächtele R Fingerhut A Kohlschütter RI Kelley KM Gibson, Am J Med Genet 1998 78 408 412 10.1002/(SICI)1096-8628(19980806)78:5<408::AID- AJMG3>3.0.CO;2-H 9714005
11. Novel genotype of mevalonic aciduria with fatalities in premature siblings. P Raupp E Varady M Duran RJA Wanders HR Waterham SM Houten, Arch Dis Child Fetal Neonatal Ed 2004 89 F90 F91 10.1136/fn.89.1.F90 14711867
12. Mevalonic aciduria in 3 siblings: a new recognizable metabolic encephalopathy. J Mancini N Philip B Chabrol P Divry MO Rolland N Pinsard, Pediatr Neurol 1993 9 243 246 10.1016/0887-8994(93)90095-T 8352861
13. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. J Frenkel SM Houten HR Waterham RJ Wanders GT Rijkers M Duran TW Kuijpers W van Luijk BT Poll-The W Kuis, Rheumatology (Oxford) 2001 40 579 584 10.1093/rheumatology/40.5.579 11371670
14. Facts and artefacts in mevalonic aciduria: development of a stable isotope dilution GCMS assay for mevalonic acid and its application to physiological fluids, tissue samples, prenatal diagnosis and carrier detection. GF Hoffmann L Sweetman HJ Bremer DH Hunneman J Hyanek V Kozich W Lehnert WL Nyhan I Speidel FK Trefz, Clin Chim Acta 1991 198 209 227 10.1016/0009-8981(91) 90355-G 1653652
15. Inborn errors of cholesterol biosynthesis. RI Kelley, Adv Pediatr 2000 47 1 53 10959439
16. Mevalonate kinase in lysates of cultured human fibroblasts and lymphoblasts: kinetic properties, assay conditions, carrier detection and measurement of residual activity in a patient with mevalonic aciduria. KM Gibson JL Lohr RL Broock G Hoffmann WL Nyhan L Sweetman IK Brandt RS Wappner PI Bader, Enzyme 1989 41 47 55 2543551
17. Mevalonate kinase assay using DEAE-cellulose column chromatography and complementation analysis in mevalonic aciduria. GF Hoffmann SU Brendel SR Scharfschwerdt YS Shin IM Speidel KM Gibson, J Inherit Metab Dis 1992 15 738 746 10.1007/BF01800016 1331607
18. Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency. E Mayatepek GF Hoffmann HJ Bremer, J Pediatr 1993 123 96 98 10.1016/S0022-3476(05)81548-3 8391572
19. Immunological studies in the hyper-immunoglubulin D syndrome. A Haraldsson CM Weemaes AW De Boer JA Bakkeren GB Stoelinga, J Clin Immunol 1992 12 424 428 10.1007/BF00918854 1287034
20. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. SM Houten W Kuis M Duran TJ de Koning A van Royen-Kerkhof GJ Romeijn J Frenkel L Dorland MM de Barse WA Huijbers GT Rijkers HR Waterham RJ Wanders BT Poll-The, Nature Genet 1999 22 175 177 10.1038/9691 10369261
21. Hyper-immunoglubulin A in the hyperimmunoglobulinemia D syndrome. IS Klasen JH Goertz GA van de Weil CM Weemaes JW Van der Meer JP Drenth, Clin Diagn Lab Immunol 2001 8 58 61 11139196 10.1128/CDLI.8.1.58-61.2001
22. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterzygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. S Stojanov P Lohse P Lohse F Hoffmann ED Renner S Zellerer A Kery YS Shin D Haas GF Hoffmann BH Belohradsky, Arthritis Rheum 2004 50 1951 1958 10.1002/art.20264 15188372
23. Inherited disorders of cholesterol biosynthesis. D Haas RI Kelley GF Hoffmann, Neuropediatrics 2001 32 113 122 10.1055/s-2001-16618 11521206
24. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. A Simon E Drewe JWM van der Meer RJ Powell RI Kelley AF Stalenhoef JPH Drenth, Clin Pharmacol Ther 2004 75 476 483 10.1016/j.clpt.2004.01.012 15116060
25. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. EJ Bodar JCH van der Hilst Drenth JWMJPH van der Meer A Simon, Neth J Med 2005 63 260 264 16093577
26. MVK mutations and associated clinical features in Italian patients affected with autoinflammatroy disorders and recurrent fever. A D'Osualdo P Picco F Caroli M Gattorno R Giacchino P Fortini F Corona A Tommasini G Salvi F Specchia L Obici A Meini A Ricci M Seri R Ravazzolo A Martini I Ceccherini, Eur J Hum Genet 2004 12 1 7 10.1038/sj.ejhg.5201139
27. Increased urinary leukotriene E(4) during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome. J Frenkel MA Willemsen CM Weemaes L Dorland E Mayatepek, Arch Dis Child 2001 85 158 159 10.1136/adc.85.2.158 11466192